These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
759 related articles for article (PubMed ID: 10800172)
1. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético. Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278 [TBL] [Abstract][Full Text] [Related]
3. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250 [TBL] [Abstract][Full Text] [Related]
4. [Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients]. Tomás JF; Peñarrubia MJ; García JA; Figuera A; Gómez-García de Soria V; Steegmann JL; Arranz R; Cámara R; Gabriel R; Vázquez L Med Clin (Barc); 1995 Nov; 105(16):605-11. PubMed ID: 8523939 [TBL] [Abstract][Full Text] [Related]
5. [Bone marrow transplantation from unrelated donors in chronic myeloid leukemia: the results in 15 patients]. Sierra J; Carreras E; Rovira M; Batlle M; Urbano-Ispizua A; Marín P; Besson I; Merino A; Algara M; Cervantes F Med Clin (Barc); 1995 May; 104(18):689-94. PubMed ID: 7769878 [TBL] [Abstract][Full Text] [Related]
6. The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. Dresse MF; Boogaerts M; Vermylen C; Noens L; Ferrant A; Schots R; Doyen C; Bron D; Berneman Z; Ferster A; Benoit Y; Demuynck H; Beguin Y Haematologica; 1999 Jul; 84(7):637-42. PubMed ID: 10406907 [TBL] [Abstract][Full Text] [Related]
7. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
8. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428 [TBL] [Abstract][Full Text] [Related]
10. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682 [TBL] [Abstract][Full Text] [Related]
11. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia. Drobyski WR; Pelz C; Kabler-Babbitt C; Hessner M; Baxter-Lowe LA; Keever-Taylor CA Biol Blood Marrow Transplant; 1998; 4(1):3-12. PubMed ID: 9701386 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Millot F; Esperou H; Bordigoni P; Dalle JH; Michallet M; Michel G; Bourhis JL; Kuenz M; Blaise D; Garban F; Plouvier E; Rome A; Guilhot J; Guilhot F Bone Marrow Transplant; 2003 Nov; 32(10):993-9. PubMed ID: 14595387 [TBL] [Abstract][Full Text] [Related]
13. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Aschan J; Ringdén O Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562 [TBL] [Abstract][Full Text] [Related]
16. Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors: the Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético). Martínez C; Gomez V; Tomás JF; Parody R; Sureda A; Sanz G; Cañizo C; Díez JL; Boqué C; Bone Marrow Transplant; 2005 Aug; 36(4):301-6. PubMed ID: 15968278 [TBL] [Abstract][Full Text] [Related]
17. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910 [TBL] [Abstract][Full Text] [Related]
18. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia. Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677 [TBL] [Abstract][Full Text] [Related]
19. Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome. Enright H; Daniels K; Arthur DC; Dusenbery KE; Kersey JH; Kim T; Miller WJ; Ramsay NK; Vercellotti GM; Weisdorf DJ; McGlave PB Bone Marrow Transplant; 1996 Apr; 17(4):537-42. PubMed ID: 8722351 [TBL] [Abstract][Full Text] [Related]
20. Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase. Schattenberg A; Preijers F; Mensink E; Bär B; Schaap N; Geurts van Kessel A; van der Maazen R; de Witte T Bone Marrow Transplant; 1997 Jun; 19(12):1205-12. PubMed ID: 9208114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]